| Authors: |
Clark AS; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Zhao F; Dana Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., Klein P; Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, New York., Montero AJ; University Hospitals/Seidman Cancer Center, Case Western Reserve University, Cleveland, Ohio., Falkson C; University of Rochester, Rochester, New York., Krill-Jackson E; University of Miami, Miami, Florida., Rowland K; Carle Cancer Center, Urbana, Illinois., Sardesai S; Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Incorvati J; Fox Chase Cancer Center, Philadelphia, Pennsylvania., Dillon P; University of Virginia, Charlottesville, Virginia., Wolff AC; Johns Hopkins University, Baltimore, Maryland., Trauger R; Oncolytics Biotech, San Diego, California., Heineman TC; Oncolytics Biotech, San Diego, California., Coffey MC; Oncolytics Biotech, Calgary, Alberta., Miller KD; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana. |
